Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity

Stefania Scala, Katja Wosikowski, Paraskevi Giannakakou, Paola Valle, June L. Biedler, Barbara A. Spengler, Enrico Lucarelli, Susan E. Bates, Carol J. Thiele

Research output: Contribution to journalArticle

Abstract

Brain-derived neurotrophic factor (BDNF) and its receptors are necessary for the survival and development of many neuronal cells. Because BDNF and TrkB are expressed in many poor-prognosis neuroblastoma (NB) tumors, we evaluated the role of BDNF in affecting sensitivity to chemotherapeutic agents. We investigated the effects of activation of the BDNF-TrkB signal transduction pathway in two NB cell lines, 15N and SY5Y. 15N cells lack the high-affinity receptor p145TrkB and express BDNF; 15N cells were used along with ISN-TrkB cells, a subline transfected with a TrkB expression vector. In cytotoxicity assays, 15N-TrkB cells were consistently 1.4-2-fold more resistant to vinblastine than 15N cells. Drug accumulation assays showed a 50% reduction in [3H]vinblastine accumulation in 15N-TrkB cells compared with control 15N cells. Addition of 30 ng/ml BDNF resulted in a reduction to 46% of control in ISN cells and a reduction to 28% of control in 15N-TrkB cells. SY5Y cells were chosen as a second model because they lack both endogenous BDNF and TrkB expression. p145TrkB expression is induced by 1 nM retinoic acid. Vinblastine accumulation was not significantly affected by 1 nM retinoic acid in SY5Y cells. Addition of 30 ng/ml BDNF decreased [3H]vinblastine accumulation to 58% of control in SY5Y cells and decreased [3H]vinblastine accumulation to 62% of control in TrkB- expressing SY5Y cells. Although an increase in BDNF expression is seen in multidrug-resistant sublines of SY5Y and BE(2)-C NB cells, the protective effect of BDNF in vinblastine toxicity may be unrelated to mdr-1, because the activity of other agents transported by P-glycoprotein was not affected. There was no increase in mdr-1 expression in 1 nM RA SY5Y cells and 15N- TrkB cells, as assessed by Northern blot analysis. In addition to the effects of BDNF on vinblastine cytotoxicity and accumulation, there was an inhibition in the ability of vinblastine to depolymerize tubulin in BDNF- treated cells. Thus, BDNF and TrkB may partially rescue NB cells from vinblastine toxicity and thereby may contribute to a more chemoresistant phenotype.

Original languageEnglish
Pages (from-to)3737-3742
Number of pages6
JournalCancer Research
Volume56
Issue number16
Publication statusPublished - Aug 15 1996

Fingerprint

Vinblastine
Brain-Derived Neurotrophic Factor
Neuroblastoma
Tretinoin
trkB Receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Scala, S., Wosikowski, K., Giannakakou, P., Valle, P., Biedler, J. L., Spengler, B. A., ... Thiele, C. J. (1996). Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Research, 56(16), 3737-3742.

Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. / Scala, Stefania; Wosikowski, Katja; Giannakakou, Paraskevi; Valle, Paola; Biedler, June L.; Spengler, Barbara A.; Lucarelli, Enrico; Bates, Susan E.; Thiele, Carol J.

In: Cancer Research, Vol. 56, No. 16, 15.08.1996, p. 3737-3742.

Research output: Contribution to journalArticle

Scala, S, Wosikowski, K, Giannakakou, P, Valle, P, Biedler, JL, Spengler, BA, Lucarelli, E, Bates, SE & Thiele, CJ 1996, 'Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity', Cancer Research, vol. 56, no. 16, pp. 3737-3742.
Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA et al. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Research. 1996 Aug 15;56(16):3737-3742.
Scala, Stefania ; Wosikowski, Katja ; Giannakakou, Paraskevi ; Valle, Paola ; Biedler, June L. ; Spengler, Barbara A. ; Lucarelli, Enrico ; Bates, Susan E. ; Thiele, Carol J. / Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. In: Cancer Research. 1996 ; Vol. 56, No. 16. pp. 3737-3742.
@article{99ef3d0610d9443c8c47d494d7706324,
title = "Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity",
abstract = "Brain-derived neurotrophic factor (BDNF) and its receptors are necessary for the survival and development of many neuronal cells. Because BDNF and TrkB are expressed in many poor-prognosis neuroblastoma (NB) tumors, we evaluated the role of BDNF in affecting sensitivity to chemotherapeutic agents. We investigated the effects of activation of the BDNF-TrkB signal transduction pathway in two NB cell lines, 15N and SY5Y. 15N cells lack the high-affinity receptor p145TrkB and express BDNF; 15N cells were used along with ISN-TrkB cells, a subline transfected with a TrkB expression vector. In cytotoxicity assays, 15N-TrkB cells were consistently 1.4-2-fold more resistant to vinblastine than 15N cells. Drug accumulation assays showed a 50{\%} reduction in [3H]vinblastine accumulation in 15N-TrkB cells compared with control 15N cells. Addition of 30 ng/ml BDNF resulted in a reduction to 46{\%} of control in ISN cells and a reduction to 28{\%} of control in 15N-TrkB cells. SY5Y cells were chosen as a second model because they lack both endogenous BDNF and TrkB expression. p145TrkB expression is induced by 1 nM retinoic acid. Vinblastine accumulation was not significantly affected by 1 nM retinoic acid in SY5Y cells. Addition of 30 ng/ml BDNF decreased [3H]vinblastine accumulation to 58{\%} of control in SY5Y cells and decreased [3H]vinblastine accumulation to 62{\%} of control in TrkB- expressing SY5Y cells. Although an increase in BDNF expression is seen in multidrug-resistant sublines of SY5Y and BE(2)-C NB cells, the protective effect of BDNF in vinblastine toxicity may be unrelated to mdr-1, because the activity of other agents transported by P-glycoprotein was not affected. There was no increase in mdr-1 expression in 1 nM RA SY5Y cells and 15N- TrkB cells, as assessed by Northern blot analysis. In addition to the effects of BDNF on vinblastine cytotoxicity and accumulation, there was an inhibition in the ability of vinblastine to depolymerize tubulin in BDNF- treated cells. Thus, BDNF and TrkB may partially rescue NB cells from vinblastine toxicity and thereby may contribute to a more chemoresistant phenotype.",
author = "Stefania Scala and Katja Wosikowski and Paraskevi Giannakakou and Paola Valle and Biedler, {June L.} and Spengler, {Barbara A.} and Enrico Lucarelli and Bates, {Susan E.} and Thiele, {Carol J.}",
year = "1996",
month = "8",
day = "15",
language = "English",
volume = "56",
pages = "3737--3742",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity

AU - Scala, Stefania

AU - Wosikowski, Katja

AU - Giannakakou, Paraskevi

AU - Valle, Paola

AU - Biedler, June L.

AU - Spengler, Barbara A.

AU - Lucarelli, Enrico

AU - Bates, Susan E.

AU - Thiele, Carol J.

PY - 1996/8/15

Y1 - 1996/8/15

N2 - Brain-derived neurotrophic factor (BDNF) and its receptors are necessary for the survival and development of many neuronal cells. Because BDNF and TrkB are expressed in many poor-prognosis neuroblastoma (NB) tumors, we evaluated the role of BDNF in affecting sensitivity to chemotherapeutic agents. We investigated the effects of activation of the BDNF-TrkB signal transduction pathway in two NB cell lines, 15N and SY5Y. 15N cells lack the high-affinity receptor p145TrkB and express BDNF; 15N cells were used along with ISN-TrkB cells, a subline transfected with a TrkB expression vector. In cytotoxicity assays, 15N-TrkB cells were consistently 1.4-2-fold more resistant to vinblastine than 15N cells. Drug accumulation assays showed a 50% reduction in [3H]vinblastine accumulation in 15N-TrkB cells compared with control 15N cells. Addition of 30 ng/ml BDNF resulted in a reduction to 46% of control in ISN cells and a reduction to 28% of control in 15N-TrkB cells. SY5Y cells were chosen as a second model because they lack both endogenous BDNF and TrkB expression. p145TrkB expression is induced by 1 nM retinoic acid. Vinblastine accumulation was not significantly affected by 1 nM retinoic acid in SY5Y cells. Addition of 30 ng/ml BDNF decreased [3H]vinblastine accumulation to 58% of control in SY5Y cells and decreased [3H]vinblastine accumulation to 62% of control in TrkB- expressing SY5Y cells. Although an increase in BDNF expression is seen in multidrug-resistant sublines of SY5Y and BE(2)-C NB cells, the protective effect of BDNF in vinblastine toxicity may be unrelated to mdr-1, because the activity of other agents transported by P-glycoprotein was not affected. There was no increase in mdr-1 expression in 1 nM RA SY5Y cells and 15N- TrkB cells, as assessed by Northern blot analysis. In addition to the effects of BDNF on vinblastine cytotoxicity and accumulation, there was an inhibition in the ability of vinblastine to depolymerize tubulin in BDNF- treated cells. Thus, BDNF and TrkB may partially rescue NB cells from vinblastine toxicity and thereby may contribute to a more chemoresistant phenotype.

AB - Brain-derived neurotrophic factor (BDNF) and its receptors are necessary for the survival and development of many neuronal cells. Because BDNF and TrkB are expressed in many poor-prognosis neuroblastoma (NB) tumors, we evaluated the role of BDNF in affecting sensitivity to chemotherapeutic agents. We investigated the effects of activation of the BDNF-TrkB signal transduction pathway in two NB cell lines, 15N and SY5Y. 15N cells lack the high-affinity receptor p145TrkB and express BDNF; 15N cells were used along with ISN-TrkB cells, a subline transfected with a TrkB expression vector. In cytotoxicity assays, 15N-TrkB cells were consistently 1.4-2-fold more resistant to vinblastine than 15N cells. Drug accumulation assays showed a 50% reduction in [3H]vinblastine accumulation in 15N-TrkB cells compared with control 15N cells. Addition of 30 ng/ml BDNF resulted in a reduction to 46% of control in ISN cells and a reduction to 28% of control in 15N-TrkB cells. SY5Y cells were chosen as a second model because they lack both endogenous BDNF and TrkB expression. p145TrkB expression is induced by 1 nM retinoic acid. Vinblastine accumulation was not significantly affected by 1 nM retinoic acid in SY5Y cells. Addition of 30 ng/ml BDNF decreased [3H]vinblastine accumulation to 58% of control in SY5Y cells and decreased [3H]vinblastine accumulation to 62% of control in TrkB- expressing SY5Y cells. Although an increase in BDNF expression is seen in multidrug-resistant sublines of SY5Y and BE(2)-C NB cells, the protective effect of BDNF in vinblastine toxicity may be unrelated to mdr-1, because the activity of other agents transported by P-glycoprotein was not affected. There was no increase in mdr-1 expression in 1 nM RA SY5Y cells and 15N- TrkB cells, as assessed by Northern blot analysis. In addition to the effects of BDNF on vinblastine cytotoxicity and accumulation, there was an inhibition in the ability of vinblastine to depolymerize tubulin in BDNF- treated cells. Thus, BDNF and TrkB may partially rescue NB cells from vinblastine toxicity and thereby may contribute to a more chemoresistant phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0029778770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029778770&partnerID=8YFLogxK

M3 - Article

C2 - 8706017

AN - SCOPUS:0029778770

VL - 56

SP - 3737

EP - 3742

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 16

ER -